Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cost of Goods | 0 | 0 | 368 | 0 | 0 |
| Gross Profit | 0 | 0 | -368 | 0 | 0 |
| Operating Expenses | 4,474 | 3,733 | 2,036 | 139 | 135 |
| Operating Income | -4,474 | -3,733 | -2,404 | -139 | -135 |
| Interest Expense | N/A | N/A | N/A | 1 | 1 |
| Other Income | 1,111 | 3,733 | 0 | 140 | 136 |
| Pre-tax Income | -3,363 | N/A | -2,404 | N/A | N/A |
| Net Income Continuous | -3,363 | -3,713 | -2,404 | 80 | -170 |
| Minority Interests | N/A | 219 | N/A | N/A | N/A |
| Net Income | $-3,363 | $-3,494 | $-2,404 | $80 | $-170 |
| EPS Basic Total Ops | -0.80 | -1.00 | -1.10 | 0.60 | -1.40 |
| EPS Basic Continuous Ops | -0.80 | -1.00 | -1.10 | 0.60 | -1.40 |
| EPS Diluted Total Ops | -0.80 | -1.00 | -1.10 | 0.60 | -1.40 |
| EPS Diluted Continuous Ops | -0.80 | -1.00 | -1.10 | 0.60 | -1.40 |
| EBITDA(a) | $-4,468 | $-3,726 | $-2,397 | $-139 | $-135 |